- Home
- ASND vs WBA Comparison
ASND vs WBA Comparison
Compare ASND & WBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- WBA
- Stock Information
- Founded
- ASND 2006
- WBA 1901
- Country
- ASND Denmark
- WBA United States
- Employees
- ASND N/A
- WBA N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- WBA Retail-Drug Stores and Proprietary Stores
- Sector
- ASND Health Care
- WBA Consumer Staples
- Exchange
- ASND Nasdaq
- WBA Nasdaq
- Market Cap
- ASND 9.1B
- WBA 9.5B
- IPO Year
- ASND 2015
- WBA N/A
- Fundamental
- Price
- ASND $157.54
- WBA $11.18
- Analyst Decision
- ASND Strong Buy
- WBA Hold
- Analyst Count
- ASND 16
- WBA 11
- Target Price
- ASND $213.88
- WBA $10.59
- AVG Volume (30 Days)
- ASND 575.6K
- WBA 9.1M
- Earning Date
- ASND 05-01-2025
- WBA 06-26-2025
- Dividend Yield
- ASND N/A
- WBA N/A
- EPS Growth
- ASND N/A
- WBA N/A
- EPS
- ASND N/A
- WBA N/A
- Revenue
- ASND $398,509,511.00
- WBA $151,946,000,000.00
- Revenue This Year
- ASND $72.24
- WBA $3.90
- Revenue Next Year
- ASND $76.59
- WBA $1.88
- P/E Ratio
- ASND N/A
- WBA N/A
- Revenue Growth
- ASND 12.06
- WBA 5.08
- 52 Week Low
- ASND $111.09
- WBA $8.08
- 52 Week High
- ASND $183.00
- WBA $18.83
- Technical
- Relative Strength Index (RSI)
- ASND 48.49
- WBA 55.63
- Support Level
- ASND $151.11
- WBA $10.90
- Resistance Level
- ASND $165.26
- WBA $11.48
- Average True Range (ATR)
- ASND 7.83
- WBA 0.11
- MACD
- ASND -1.28
- WBA 0.02
- Stochastic Oscillator
- ASND 20.71
- WBA 48.28
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About WBA Walgreens Boots Alliance Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.